Hermes Investment Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Hermes Investment Management’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,359,823	Closed	-$28.2M	–	233
2017 Q3	$28.2M	Sell	1,359,823 -262,513	-16%	-$4.44M	0.42%	80
2017 Q2	$24M	Sell	1,622,336 -150,441	-8%	-$2.51M	0.39%	96
2017 Q1	$28.3M	Buy	1,772,777 +259,696	+17%	+$3.75M	0.46%	85
2016 Q4	$19.1M	Buy	1,513,081 +566,108	+60%	+$10.5M	0.33%	112
2016 Q3	$26.5M	Buy	946,973 +62,514	+7%	+$2.1M	0.45%	86
2016 Q2	$31M	Buy	884,459 +116,920	+15%	+$3.68M	0.62%	70
2016 Q1	$22.5M	Buy	767,539 +177,233	+30%	+$5.22M	0.47%	89
2015 Q4	$20.2M	Buy	+590,306	New	+$18.4M	0.46%	90

Other funds holding DPLO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hermes Investment Management's DPLO Position: Q4 2017 in Review

Hermes Investment Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2017, closing a stake of 1,359,823 shares — an estimated $28.2M sold.

Hermes Investment Management first reported a position in DPLO in Q4 2015 and held it in 8 quarters. The position peaked at $31M in Q2 2016. 200 funds tracked by Wall St. Rank hold DPLO as of Q4 2017.

Hermes Investment Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2017 after selling out during the quarter.
Hermes Investment Management sold 1,359,823 DIPLOMAT PHARMACY, INC. shares in Q4 2017, an estimated $28.2M.
Hermes Investment Management first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2015 and held it in 8 quarters.
Hermes Investment Management's DIPLOMAT PHARMACY, INC. position peaked at $31M in Q2 2016.
200 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2017.

Based on Hermes Investment Management's 13F filing for Q4 2017, filed 24 Jan 2018.